Scancell Holdings PLC (SCLP)

Industry Biotechnology

This stock can be held in an Investment ISA, SIPP and Investment Account

Sell

9.60p

Buy

10.20p

arrow-up0.00p (+0.00%)

Prices updated at 12 Dec 2025, 17:07 GMT

Prices minimum 15 mins delay

Prices in GBX

Scancell Holdings PLC is a biopharmaceutical company focused on the cancer therapeutics market. The company's principal activity consists of the discovery and development of monoclonal antibodies and vaccines for the treatment of cancer.

FTSE All-Share

-0.48%

LSE

Important documents: Please ensure that you have read the Pre-sale Illustrations document & Doing Business with Fidelity document (incorporating the Fidelity Client Terms) and

Our Investment Fees and Charges.

In the news

Sharecast service unavailable

Press releases

09 Dec 2025

07 Nov 2025

30 Oct 2025

03 Oct 2025

16 Sep 2025

11 Sep 2025

04 Sep 2025

08 Aug 2025

04 Aug 2025

22 Jul 2025

Key dates

	Forecast date
Annual general meeting	Oct 2026
Final results	Sep 2026
Annual report	Sep 2026
Half yearly results	Jan 2026

	Previous date
Annual general meeting	Oct 2025
Final results	Sep 2025
Annual report	Sep 2025
Half yearly results	Jan 2025

Company reports

30 Apr 2025

Annual Report

Quarterly Report

Important Information

Investment values, and income from investments, can go down as well as up, so you may get back less than you invest. This is not a personal recommendation for a specific investment. If you're not sure which investments are suitable for you, consult Fidelity's advisers or another authorised financial adviser. The information contained herein: is proprietary to Morningstar and/or its content providers; may not be copied or distributed; and is not warranted to be accurate, complete or timely. Neither Morningstar nor its content providers are responsible for any damages or losses arising from any use of this information.